Rare Event for PPMS Patients Hosted by Ocrevus Manufacturer

PPMS (Primary Progressive Multiple Sclerosis) patients rarely find local patient education events geared toward them.  Since the FDA (USA) approved the first treatment effective...

Multiple sclerosis ”game changer” drug gets government subsidy in Australia

Melanie Row was enjoying a family holiday on the Gold Coast in 2016 when she noticed she didn't have control of her right thumb.The...

USA Survey Shows Most Women Newly Diagnosed with MS Have Concerns They Aren’t Discussing...

FRAZER, Pa. and AVON, Colo.–(BUSINESS WIRE)–Approximately 400,000 people in the U.S. have Multiple sclerosis (MS), an unpredictable disease of the central nervous system that...
video

University of Calgary research using acne medication to combat MS

A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), at the Cumming School of Medicine (CSM), shows...

Multiple Sclerosis: Are we close to a cure?

Hannah Nichols recently posed this question in Medical News Today, "Researchers are uncovering many potential treatment routes for MS. Could they be close to...

Revised ‘McDonald Criteria’ Expected to Speed the Diagnosis of Multiple Sclerosis

As reported by the National Multiple Sclerosis Society, the McDonald Criteria for the Diagnosis of Multiple Sclerosis have just been revised by a 30-member international...

The MS Gym Launches Membership Site!

In a much anticipated and very exciting live streaming announcement on Facebook, Misty and Trevor Wicken of The MS Gym announced the launch of...

Multiple Sclerosis Symptoms Improve with Fruits and Vegetables

Eating a healthful diet comprising fruits, vegetables, and whole grains may be linked with reduced disability and fewer multiple sclerosis symptoms among people with...
video

Cladridbine for the Treatment of Multiple Sclerosis

Dr. Daniel Kantor speaks with Dr. Kottil Rammohan, Professor of Neurology at University of Miami and Director of the MS Center about Cladribine for...

Advanced Practice Providers Treat Significantly More of their Multiple Sclerosis Patients with Monoclonal Antibody...

Market access restrictions for high efficacy Multiple Sclerosis therapies may be hindering their ability to optimally treat their clinically complex, relapsing patients, according to...

Social Media

834FollowersFollow